Letter to the Editors: Concerning “Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia” by Lee et al.

Ítems similars

• Gene therapy for glycogen storage diseases
  per: Kishnani, Priya S, et al.
  Publicat: (2019)
• Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia
  per: Brooks, Elizabeth Drake, et al.
  Publicat: (2013)
• Long-term Complications of Glycogen Storage Disease Type Ia in the Canine Model Treated with Gene Replacement Therapy
  per: Brooks, Elizabeth D., et al.
  Publicat: (2018)
• Characterization of a canine model of glycogen storage disease type IIIa
  per: Yi, Haiqing, et al.
  Publicat: (2012)
• Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
  per: Kang, Hye-Ri, et al.
  Publicat: (2019)